Dover Corporation · DOV · FY2026 Q2 · Calendar Q3 2026
Dover Raises EPS Guidance but Shares Fall 8% on Revenue Miss and Refrigeration Issues
Dover's Q2 results encapsulate a crosscurrent story: secular demand is accelerating across data-center liquid cooling, CO2 refrigeration, aerospace, space, and biopharma, now representing approximately 25% of revenue. The order book is healthy with book-to-bill at 1.06 across all five segments, and management raised full-year adjusted EPS guidance. Yet the stock fell roughly 8% on the print. The disconnect centers on near-term execution: a refrigeration facility consolidation caused throughput shortfalls that cost an estimated 1 to 1.5% of organic growth and pressured margins, and revenue missed consensus. Investors must weigh whether the guidance raise already prices in a clean H2 recovery or whether execution risk in refrigeration and the heat-exchanger capacity ramp could persist. The prior quarter set a high bar with double-digit revenue growth and 24% bookings growth; Q2's 7%…
Company context
Snapshot as of publicationDover Corporation operates as a global enterprise, supplying a wide array of industrial equipment, essential components, consumable products, replacement parts, software and digital platforms, and comprehensive support services. Its Engineered Products division delivers diverse machinery, parts, software, and solutions tailored for various industries, including automotive aftermarket service, waste management, industrial automation, aerospace and defense, heavy-duty winching and hoisting, and fluid dispensing. This segment also manufactures specific items such as manual and power clamps, rotary and linear mechanical indexers, conveyors, robotic pick-and-place units, glove ports, manipulators, and end-of-arm tooling like grippers, slides, and end effectors. The Clean Energy & Fueling segment focuses on providing components, equipment, software, and services crucial for the secure transportation of both traditional and sustainable fuels, along with other hazardous materials, throughout the supply chain.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 4, 2026 |
| Seaport Global | Buy | Buy | Maintain | Apr 28, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 13, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Mar 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 30, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 5, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 13, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 12, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 28, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| B of A Securities | Buy | Buy | Maintain | Apr 11, 2023 |
| Bank of America | Buy | Buy | Maintain | Sep 26, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 12, 2018 |
| Stifel | Hold | Hold | Maintain | Sep 12, 2018 |
| Vertical Research | Buy | Hold | Upgrade | Jan 3, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 7, 2016 |
| Bernstein | Outperform | Market Perform | Upgrade | Jun 10, 2016 |
| Nomura | Buy | Buy | Maintain | Mar 7, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 16, 2015 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 3, 2015 |
| Global Hunter Securities | Buy | Buy | Maintain | Oct 18, 2013 |
| Ascendiant Capital | Neutral | Buy | Downgrade | Oct 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $201.75. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Analyst unavailable | $227 | $203.68 | +12.5% | Jul 24, 2026 |
| Robert W. Baird | Michael Halloran | $270 | $197.8 | +33.8% | Jul 24, 2026 |
| BMO Capital | Daniel DiCicco | $240 | $197.8 | +19.0% | Jul 24, 2026 |
| Wolfe Research | Nigel Coe | $262 | $213.55 | +29.9% | Jul 9, 2026 |
| Morgan Stanley | Christopher Snyder | $230 | $215.74 | +14.0% | Jun 4, 2026 |
| Seaport Global | Analyst unavailable | $265 | $224.49 | +31.4% | Apr 28, 2026 |
| Deutsche Bank | Analyst unavailable | $229 | $227.3 | +13.5% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $252 | $227.3 | +24.9% | Apr 24, 2026 |
| BMO Capital | Daniel DiCicco | $250 | $228.47 | +23.9% | Apr 24, 2026 |
| Oppenheimer | Bryan Blair | $250 | $228.15 | +23.9% | Apr 24, 2026 |
| Robert W. Baird | Michael Halloran | $279 | $228.15 | +38.3% | Apr 24, 2026 |
| Barclays | Julian Mitchell | $230 | $228.15 | +14.0% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $237 | $209.21 | +17.5% | Mar 26, 2026 |
| Morgan Stanley | Christopher Snyder | $210 | $216.32 | +4.1% | Feb 4, 2026 |
| Seaport Global | Analyst unavailable | $245 | $210.52 | +21.4% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $206 | $201.49 | +2.1% | Feb 2, 2026 |
| Goldman Sachs | Analyst unavailable | $224 | $201.49 | +11.0% | Jan 31, 2026 |
| RBC Capital | Analyst unavailable | $209 | $202.53 | +3.6% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $255 | $204.72 | +26.4% | Jan 30, 2026 |
| Oppenheimer | Analyst unavailable | $232 | $207.49 | +15.0% | Jan 26, 2026 |
| RBC Capital | Deane Dray | $199 | $207.64 | -1.4% | Jan 15, 2026 |
| Wells Fargo | Joseph O'Dea | $205 | $203.5 | +1.6% | Jan 7, 2026 |
| UBS | Amit Mehrotra | $256 | $195.75 | +26.9% | Jan 4, 2026 |
| BNP Paribas | Analyst unavailable | $195 | $190.27 | -3.3% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $178.94 | -3.3% | Oct 28, 2025 |
| RBC Capital | Deane Dray | $198 | $179.82 | -1.9% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $235 | $179.82 | +16.5% | Oct 24, 2025 |
| UBS | Analyst unavailable | $200 | $179.82 | -0.9% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $206 | $186.5 | +2.1% | Jul 25, 2025 |
| Mizuho Securities | Brett Linzey | $215 | $186.7 | +6.6% | May 16, 2025 |
| RBC Capital | Analyst unavailable | $176 | $169.01 | -12.8% | Apr 25, 2025 |
| Morgan Stanley | Christopher Snyder | $185 | $163.66 | -8.3% | Apr 14, 2025 |
| Barclays | Analyst unavailable | $205 | $184.22 | +1.6% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $200 | $187.98 | -0.9% | Jan 7, 2025 |
| UBS | Amit Mehrotra | $217 | $176.23 | +7.6% | Nov 13, 2024 |
| Goldman Sachs | Joe Ritchie | $202 | $191.84 | +0.1% | Oct 30, 2024 |
| Wolfe Research | Nigel Coe | $227 | $191.03 | +12.5% | Oct 28, 2024 |
| Bank of America Securities | Andrew Obin | $210 | $192.79 | +4.1% | Oct 17, 2024 |
| Oppenheimer | Bryan Blair | $215 | $191.28 | +6.6% | Oct 16, 2024 |
| Citigroup | Andrew Kaplowitz | $218 | $189.12 | +8.1% | Sep 23, 2024 |
| RBC Capital | Deane Dray | $193 | $187.03 | -4.3% | Jul 26, 2024 |
| Robert W. Baird | Michael Halloran | $219 | $186.32 | +8.6% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $179 | $173.2 | -11.3% | Apr 4, 2024 |
| Seaport Global | Walt Liptak | $190 | $159.99 | -5.8% | Feb 5, 2024 |
| Morgan Stanley | Analyst unavailable | $152 | $152.88 | -24.7% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $157 | $154.66 | -22.2% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $174 | $152.35 | -13.8% | Feb 1, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $139 | $119.36 | -31.1% | Oct 12, 2022 |
| Deutsche Bank | Nicole DeBlase | $132 | $128.25 | -34.6% | Jul 22, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $149 | $133.19 | -26.1% | Jun 7, 2022 |
| Morgan Stanley | Analyst unavailable | $161 | $140.87 | -20.2% | Apr 22, 2022 |
| Barclays | Analyst unavailable | $155 | $140.86 | -23.2% | Apr 22, 2022 |
| Wells Fargo | Analyst unavailable | $159 | $141 | -21.2% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $162 | $144.16 | -19.7% | Apr 22, 2022 |
| Barclays | Julian Mitchell | $190 | $153.92 | -5.8% | Apr 5, 2022 |
| Deutsche Bank | Nicole Deblase | $176 | $178.77 | -12.8% | Jan 10, 2022 |
| Wells Fargo | Joseph O'Dea | $184 | $168.44 | -8.8% | Dec 20, 2021 |
| Bank of America Securities | Andrew Obin | $205 | $167.82 | +1.6% | Oct 20, 2021 |
Track every rating change on DOV the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow DOV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue grew 7% YoY (5% organic) with all five segments posting positive organic growth, but missed consensus by approximately $19M due to refrigeration throughput shortfalls. Adjusted EPS of $2.74 beat consensus by $0.02. Book-to-bill remained above 1 at 1.06, though absolute order dollars declined sequentially from Q1's elevated level. Management raised full-year adjusted EPS guidance and committed to continued double-digit earnings growth. The Secora acquisition continues to outperform its underwriting case, expanding Dover's electrification and data-center exposure. Plans were announced to double liquid-cooling heat exchanger capacity within 12 months. Space-related cryogenic components are targeted to contribute $50M in revenue this year. The stock fell approximately 7.8% on the earnings day on roughly 3.9x normal volume.
Guidance delta
Full-year adjusted EPS guidance was raised, along with the organic growth outlook. Prior-quarter guidance had been maintained with an expectation of reaching the top end of the range; this quarter the raise was explicit, reflecting first-half performance and second-half visibility from the order book. CapEx guidance was maintained at $190 to $210M. Free cash flow guidance of 14 to 16% of revenue was reaffirmed. Management expects H2 profitability to be materially better than H1 as refrigeration throughput improves and remaining facility redundancy costs are eliminated.
Key takeaways
- Revenue grew 7% YoY with 5% organic growth across all five segments; adjusted EPS of $2.74 beat consensus by $0.02.
- Book-to-bill of 1.06 across all five segments, a rare breadth event for Dover's diversified portfolio.
- Secular growth markets now represent approximately 25% of revenue, up from roughly 20% at the end of Q1.
- Full-year adjusted EPS guidance raised; management committed to continued double-digit EPS growth.
- Refrigeration throughput shortfall cost an estimated 1 to 1.5% of organic growth; CEO took responsibility and expects H2 recovery.
- Secora acquisition exceeding its underwriting case; industrial M&A pipeline improving as more assets come to market.
Management priorities
- Resolve refrigeration throughput issues by completing facility consolidation and ramping labor through H2 2026.
- Double liquid-cooling heat exchanger capacity at SWEP within 12 months to meet exceptional data-center demand.
- Pursue selective acquisitions in attractive end markets as industrial M&A opportunities expand.
- Continue capacity expansion across aerospace, biopharma, and CO2 refrigeration platforms.
- Maintain disciplined capex spending while preserving balance-sheet flexibility for strategic capital deployment.
Related earnings events
IndustrialsSources
- Earnings call transcript and parsed analysis · 2026-07-23T16:05:10.849847+00:00
- FN2 earnings calendar · 2026-07-30T01:23:13.872335+00:00
- Polygon adjusted daily market bars · 2026-07-30T15:51:23.466240+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T15:51:23.463499+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.